Whatever happened to that therapeutic video game?
Back in 2018, Akili Interactive Labs was poised for an audacious first, making its case that the FDA should approve a video game as a treatment for ADHD. Then 18 months went by, all without a word on the FDA process.
As STAT’s Rebecca Robbins reports, that could be an ominous sign for Akili’s ambitions. The company wouldn’t say whether regulators had problems with its application or wanted to see another clinical trial. CEO Eddie Martucci said the company stands by the game’s demonstrated benefits but conceded that the process is taking “longer than some of us had hoped.”
Akili’s game, Project Evo, is a tablet-based app that rewards players for focusing on specific tasks. The idea, according to the company, is to activate certain neural networks in the brain and thereby treat ADHD.
Read more.
As STAT’s Rebecca Robbins reports, that could be an ominous sign for Akili’s ambitions. The company wouldn’t say whether regulators had problems with its application or wanted to see another clinical trial. CEO Eddie Martucci said the company stands by the game’s demonstrated benefits but conceded that the process is taking “longer than some of us had hoped.”
Akili’s game, Project Evo, is a tablet-based app that rewards players for focusing on specific tasks. The idea, according to the company, is to activate certain neural networks in the brain and thereby treat ADHD.
Read more.
.png)
No hay comentarios:
Publicar un comentario